Metraipolis › archive › dc_c10cb1faae38

Third-Line and Later Susceptibility-Guided Helicobacter pylori Eradication Therapies: A Multicenter Study of Vonoprazan-Amoxicillin-Sitafloxacin/Rifabutin… — Europe PMC PMID:41598371

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41598371
DOI
10.3390/jcm15020434
License (as archived)
solo-consultazione
Archived
2026-11-07T01:06:21.465Z
SHA-256 of the archived text
5f8d5b5f13ae1dfeea39263ca9d90abc3ea631d8bcd7d8df2e0c12dbca52a6a6
Stable URL of this page
https://metraipolis.com/documento/dc_c10cb1faae38

How to cite

Third-Line and Later Susceptibility-Guided Helicobacter pylori Eradication Therapies: A Multicenter Study of Vonoprazan-Amoxicillin-Sitafloxacin/Rifabutin… — Europe PMC PMID:41598371 — Europe PMC (en), https://europepmc.org/article/MED/41598371 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c10cb1faae38 (Metraipolis archive dc_c10cb1faae38, sha256 5f8d5b5f13ae1dfeea39263ca9d90abc3ea631d8bcd7d8df2e0c12dbca52a6a6)
BibTeX
@misc{dcc10cb1faae38,
  title = {Third-Line and Later Susceptibility-Guided Helicobacter pylori Eradication Therapies: A Multicenter Study of Vonoprazan-Amoxicillin-Sitafloxacin/Rifabutin… — Europe PMC PMID:41598371},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41598371},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c10cb1faae38; sha256 5f8d5b5f13ae1dfeea39263ca9d90abc3ea631d8bcd7d8df2e0c12dbca52a6a6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41598371. Agents can read the archived copy with the MCP tool read_document.